Alhefzi Muayyad, Voineskos Sophocles H, Coroneos Christopher J, Thoma Achilleas, Avram Ronen
Division of Plastic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
Plast Reconstr Surg Glob Open. 2020 Apr 11;8(10):e3180. doi: 10.1097/GOX.0000000000003180. eCollection 2020 Oct.
Abdominal-based perforator flaps are the gold standard for autologous breast reconstruction. However, among patients with a small-to-medium amount of redundant abdominal tissue, this may result in an inadequate breast mound. Secondary implant augmentation has been reported as one method to augment volume, address breast mound asymmetry, and enhance overall aesthetic outcome. We aim to analyze postoperative complications associated with the secondary implant augmentation following a primary breast reconstruction with abdominal perforator flaps.
This retrospective study included patients who underwent secondary implant augmentation following abdominal-based perforator flap breast reconstruction. Patient characteristics, immediate versus delayed reconstruction, type of flap used, indication for secondary augmentation as well as perioperative and postoperative complication including flap or implant loss were reviewed and analyzed.
Twenty-four patients met inclusion criteria. Forty flaps were performed (16 bilateral and 8 unilateral). A total of 36 implants were placed in subpectoral plane in a secondary revision procedure. The mean time between secondary augmentation and index procedure was 22 months. Average implant volume was 270 g. No intraoperative complication or flap loss was recorded. Postoperative surgical site infection occurred in a total of 4 patients (17%) with 3 patients requiring explantation of a total of 4 implants.
Secondary augmentation of abdominal-based perforator flap using a permanent implant is an effective method to address volume and asymmetry and to enhance aesthetic outcome. In our study, however, we observed a higher than expected rate of postoperative infection.
腹壁穿支皮瓣是自体乳房重建的金标准。然而,在腹部冗余组织量为中少量的患者中,这可能导致乳房隆起不足。二次植入隆乳术已被报道为一种增加乳房体积、解决乳房隆起不对称问题并提高整体美学效果的方法。我们旨在分析在腹壁穿支皮瓣一期乳房重建后进行二次植入隆乳术相关的术后并发症。
这项回顾性研究纳入了在腹壁穿支皮瓣乳房重建后进行二次植入隆乳术的患者。回顾并分析了患者特征、即刻与延迟重建、所使用皮瓣的类型、二次隆乳的指征以及围手术期和术后并发症,包括皮瓣或植入物丢失情况。
24例患者符合纳入标准。共进行了40例皮瓣手术(16例双侧和8例单侧)。在二次修复手术中,共有36枚植入物放置于胸大肌下平面。二次隆乳与初次手术之间的平均时间为22个月。平均植入物体积为270克。未记录到术中并发症或皮瓣丢失情况。共有4例患者(17%)发生术后手术部位感染,其中3例患者需要取出总共4枚植入物。
使用永久性植入物对腹壁穿支皮瓣进行二次隆乳是解决乳房体积和不对称问题并提高美学效果的有效方法。然而,在我们的研究中,我们观察到术后感染率高于预期。